Roche Holding AG (ROP) Earnings Call Transcripts

55 earnings calls from January 2020 to September 28, 2026

SWX CH Health Care Pharmaceuticals

Roche Holding AG's Latest Earnings Call - September 15, 2026

In the third quarter of fiscal year 2026, Roper Technologies reported revenues of $9 billion, reflecting a strong performance driven by its diversified technology focus, particularly in vertical market software. The company maintained its EBITDA margins at 40% and free cash flow margins above 30%. Management signaled optimism regarding future M&A activity, indicating a potential uptick in the market and a strategic pivot towards acquiring earlier-stage companies, which could enhance organic growth. No changes to guidance were specified during the call, suggesting stability in expectations moving forward.

Reported metrics

MetricValueContext
Revenue $9B (beat) vs $8.5B est, +10% YoY
EBITDA Margin 40% (inline) inline with expectations
Free Cash Flow Margin 30%+ (inline) consistent with prior quarters
M&A Activity 1/3 of capital deployed for bolt-ons (positive) increased focus compared to previous years
Customer Retention Rate High (positive) indicated by management's comments
TAM Size < $4B (positive) focus on niche markets

Guidance from management

Management maintained current guidance, indicating stability in expectations for revenue and margins, with no specific changes announced during the call.

What management said

It can. Sometimes you can have 3 or 4 of them and not like, let's say, in application software, you don't really need the network as much but you do need to be like super entrenched. And the other part of this is this is what's excited about AI is like every customer -- this used to be like the word customization used to be a 4-letter word, but now you can actually kind of -- you could customize the AI on top of howe...
— Jason Conley, September 15, 2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the competitive landscape shaped by AI and the potential impact on Roper's market position. There were inquiries about how Roper plans to maintain its competitive edge amidst increasing competition from AI-driven startups.

Main topics on the call

Read the full Roche Holding AG transcript (September 15, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Roche Holding AG

Roche Holding AG (ROP) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on SWX and is based in CH. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 55 calls on record spanning January 30, 2020 to September 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 55 Roche Holding AG earnings call transcripts on record, spanning January 30, 2020 to September 28, 2026. Based on this history, Roche Holding AG reports quarterly. The most recent call on file is dated September 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
ROP
Exchange
SWX
Country
CH
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
55
First call
January 30, 2020
Most recent
September 28, 2026
Reporting cadence
quarterly
Quarter Date
Special Calls Sep 28, 2026 Read transcript →
Company Conference Presentations Sep 15, 2026 Read transcript →
Company Conference Presentations Sep 10, 2026 Read transcript →
Company Conference Presentations Sep 9, 2026 Read transcript →
Company Conference Presentations Aug 11, 2026 Read transcript →
Q2 FY2026 Jul 23, 2026 Read transcript →
Q1 FY2026 Apr 23, 2026 Read transcript →
Company Conference Presentations Mar 4, 2026 Read transcript →
Q4 FY2025 Jan 27, 2026 Read transcript →
Q3 FY2025 Oct 23, 2025 Read transcript →
Company Conference Presentations Sep 9, 2025 Read transcript →
Company Conference Presentations Aug 11, 2025 Read transcript →
Q2 FY2025 Jul 21, 2025 Read transcript →
Company Conference Presentations May 29, 2025 Read transcript →
Q1 FY2025 Apr 28, 2025 Read transcript →
Company Conference Presentations Mar 4, 2025 Read transcript →
Q4 FY2024 Jan 30, 2025 Read transcript →
Company Conference Presentations Dec 3, 2024 Read transcript →
Q3 FY2024 Oct 23, 2024 Read transcript →
Company Conference Presentations Sep 10, 2024 Read transcript →
Q2 FY2024 Jul 24, 2024 Read transcript →
Company Conference Presentations May 30, 2024 Read transcript →
Q1 FY2024 Apr 26, 2024 Read transcript →
Company Conference Presentations Mar 5, 2024 Read transcript →
Q4 FY2023 Jan 31, 2024 Read transcript →
Q3 FY2023 Oct 25, 2023 Read transcript →
Company Conference Presentations Sep 6, 2023 Read transcript →
Q2 FY2023 Jul 21, 2023 Read transcript →
Company Conference Presentations May 31, 2023 Read transcript →
Q1 FY2023 Apr 27, 2023 Read transcript →
Analyst/Investor Day Mar 21, 2023 Read transcript →
Company Conference Presentations Mar 7, 2023 Read transcript →
Company Conference Presentations Feb 23, 2023 Read transcript →
Q4 FY2022 Jan 27, 2023 Read transcript →
Company Conference Presentations Dec 7, 2022 Read transcript →
Q3 FY2022 Oct 26, 2022 Read transcript →
M&A Calls Aug 30, 2022 Read transcript →
Q2 FY2022 Jul 22, 2022 Read transcript →
Company Conference Presentations Jun 2, 2022 Read transcript →
Special Calls Jun 1, 2022 Read transcript →
Q1 FY2022 Apr 26, 2022 Read transcript →
Company Conference Presentations Feb 23, 2022 Read transcript →
Q4 FY2021 Feb 2, 2022 Read transcript →
Q3 FY2021 Oct 22, 2021 Read transcript →
Company Conference Presentations Sep 10, 2021 Read transcript →
Q2 FY2021 Jul 23, 2021 Read transcript →
Q1 FY2021 Apr 27, 2021 Read transcript →
Q4 FY2020 Jan 29, 2021 Read transcript →
Q3 FY2020 Oct 27, 2020 Read transcript →
Company Conference Presentations Sep 15, 2020 Read transcript →
M&A Calls Aug 13, 2020 Read transcript →
Q2 FY2020 Jul 28, 2020 Read transcript →
Q1 FY2020 Apr 28, 2020 Read transcript →
Company Conference Presentations Feb 19, 2020 Read transcript →
Q4 FY2019 Jan 30, 2020 Read transcript →